Prices increased on 810 different medications by the end of January 2021, not only on branded medications but also some generic drugs, according to a pricing report from GoodRx Health.

The U.S. Food and Drug Administration withdrew the regulatory agency’s draft guidance on statistical methods to evaluate the analytical similarity between branded drugs and biosimilars.